Novel azetidinyl and pyrrolidinyl compounds are ligands of melanocortin-4 receptors and are useful for treating conditions responsive to the modulation of melanocortin-4 receptors such as obesity, diabetes, and sexual dysfunction. ##STR1##
Web www.patentalert.com
< NK1 antagonists
< Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor
> 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
> 3-azabicyclo[3.1.0]hexane derivatives
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT